ArticleCancer medicine2023

Real-world data on the efficacy and safety of immune-checkpoint inhibitors in elderly patients with non-small cell lung cancer.

Daisuke Morinaga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.